Drug Use Investigation for XYZAL®

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Cetirizine; Levocetirizine

Criteria

Inclusion Criteria:

• Must be the first time for taking levocetirizine tablet

Exclusion Criteria:

• As this is PMS study, there are no exclusion criteria.